Abstract

Oseltamivir 12-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2007 - Hormone Replacement Therapy

Page(s): 332

Download in electronic PDF format for $75

Abstract

A formulation for preparing Oseltamivir 12-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2007 Pg. 332	Oseltamivir 12-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2018 Pg. 323	Oseltamivir Phosphate 15 mg/mL in SyrSpend SF Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 164-176	Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Author(s): Ford Stephen M, Kloesel Lawson G, Grabenstein John D
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 82-85	Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Author(s): Voudrie Mark A II, Allen D Brett
Nov/Dec 2018 Pg. 516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Sep/Oct 1997 Pg. 323	Diltiazem HCl 12-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 493	Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 416	Sumatriptan Succinate 12-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 420	Nitazoxanide 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 420	Sorafenib 20-mg/mL in Oil Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 151	Acyclovir 200-mg/5-mL Oral Suspension (From the Injection) Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 47	Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 43	Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 240-241	Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid
Sep/Oct 2021 Pg. 412	Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 66-75	Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
May/Jun 2018 Pg. 263	Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension Author(s):